2026 NPPES data Neurology Physician NPI 1619923786 M.D.
Verify on CMS →

ANDREW MAMMEN, M.D.

Neurology Physician in BALTIMORE, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
229
Medicare Part D claims · 17 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
38%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$89.52
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ANDREW MAMMEN, M.D. filed 229 Medicare Part D claims in 2023 as a Neurology Physician in BALTIMORE, Maryland, prescribing 38% generic.

229
Part D claims, 2023
38%
generic prescribing
$89.52
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANDREW MAMMEN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

229 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ANDREW MAMMEN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANDREW MAMMEN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 05/26/2006

NPI 1619923786

Primary specialty

Neurology Physician

Mid-sized

19,866 US NPIs in this specialty

Medicare Part D claims

229 83% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

Specialty distribution in Maryland

How Neurology Physician compares to other specialties among Maryland providers

Maryland providers

Neurology Physician share within Maryland

1. Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neurology Physician share within Maryland

Specialty board-certification context

Estimated specialty board-certified rate — Neurology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neurology Physician ABMS/AOA estimate

Est. board-certified rate (Neurology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neurology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANDREW MAMMEN, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 4940 EASTERN AVE, BALTIMORE, MD, 21224, with a listed phone of (410) 550-5624. NPI 1619923786 was issued on 05/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAMMEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 229 prescription claims written by this provider, covering 17 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 62% brand-name and 38% generic by claim count, with an opioid prescribing rate of 5.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4940 EASTERN AVE
BALTIMORE, MD 21224

Provider Details

NPI 1619923786
Specialty Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 05/26/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANDREW MAMMEN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$90

Largest payer

UCB, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

ANDREW MAMMEN, M.D. — brand share 62.0%
Specialty average (est.)

62% brand-name claims vs 38% generic, on 229 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

229
Total Claims
$1.6M
Total Drug Cost
17
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
272
Total Day Supply
7,805
Brand vs Generic
62% brand / 38% generic
Brand Drug Cost
$1.6M
Generic Drug Cost
$6K
Opioid Claims
12 (5.2% rate)

Patient Demographics

Average Patient Age
67.7 years
Avg HCC Risk Score
1.60

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANDREW MAMMEN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Privigen
Immun Glob G(Igg)/Pro/Iga 0-50
89
Methotrexate
Methotrexate Sodium
21
Gammagard Liquid
Immun Glob G(Igg)/Gly/Iga Ov50
19
Mycophenolate Mofetil
19
Azathioprine
18
Gammaked
Immune Globul G/Gly/Iga Avg 46
13
Gamunex-C
Immune Globul G/Gly/Iga Avg 46
13
Tramadol Hcl Er
Tramadol Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How ANDREW MAMMEN, M.D. fits within the Neurology Physician landscape nationally.

19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

ANDREW MAMMEN, M.D.'s 229 claims are below the specialty average of 1,309.

Nearby Neurology Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as MAMMEN.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANDREW MAMMEN, M.D.'s specialty?
ANDREW MAMMEN, M.D. specializes in Neurology Physician and practices in BALTIMORE, Maryland. Credentials: M.D..
How much does ANDREW MAMMEN, M.D. prescribe under Medicare Part D?
In 2023, ANDREW MAMMEN, M.D. wrote 229 Medicare Part D claims totaling $1.6M in drug costs for 17 beneficiaries.
Where is ANDREW MAMMEN, M.D. located?
ANDREW MAMMEN, M.D. is located at 4940 EASTERN AVE, BALTIMORE, MD, 21224. Phone: (410) 550-5624.
What is ANDREW MAMMEN, M.D.'s NPI number?
ANDREW MAMMEN, M.D.'s National Provider Identifier (NPI) is 1619923786, issued on 05/26/2006.
Does ANDREW MAMMEN, M.D. prescribe more brand-name or generic drugs?
ANDREW MAMMEN, M.D.'s prescribing is 62% brand-name and 38% generic drugs by claim count, with $1.6M in brand drug costs.
Does ANDREW MAMMEN, M.D. prescribe opioids?
Yes, ANDREW MAMMEN, M.D. had 12 opioid claims in 2023 with an opioid prescribing rate of 5.2%.
How many Neurology Physician providers are there in the US?
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does ANDREW MAMMEN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ANDREW MAMMEN, M.D.'s most frequently prescribed drugs include Privigen, Methotrexate, Gammagard Liquid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANDREW MAMMEN, M.D. accept Medicare?
ANDREW MAMMEN, M.D. appears in CMS Medicare data with 229 Part D claims and 17 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANDREW MAMMEN, M.D.'s credentials?
ANDREW MAMMEN, M.D.'s NPI is 1619923786 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology